WO2002012343A3 - Nouvelles proteines et acides nucleiques les codant - Google Patents

Nouvelles proteines et acides nucleiques les codant Download PDF

Info

Publication number
WO2002012343A3
WO2002012343A3 PCT/US2001/024787 US0124787W WO0212343A3 WO 2002012343 A3 WO2002012343 A3 WO 2002012343A3 US 0124787 W US0124787 W US 0124787W WO 0212343 A3 WO0212343 A3 WO 0212343A3
Authority
WO
WIPO (PCT)
Prior art keywords
proteins
nucleic acids
acids encoding
protein coupled
coupled receptors
Prior art date
Application number
PCT/US2001/024787
Other languages
English (en)
Other versions
WO2002012343A2 (fr
Inventor
Kimberly A Spytek
Muralidhara Padigaru
Bryan D Zerhusen
Jason C Baumgartner
Li Li
Stacie J Casman
Corine A M Vernet
Robert A Ballinger
Suresh G Shenoy
Ramesh Kekuda
Catherine E Burgess
Peter S Mezes
William M Grosse
John P Ii Alsobrook
Linda Gorman
William J Larochelle
Raymond J Taupier Jr
Steven D Colman
Edward S Szekeres Jr
Original Assignee
Curagen Corp
Kimberly A Spytek
Muralidhara Padigaru
Bryan D Zerhusen
Jason C Baumgartner
Li Li
Stacie J Casman
Corine A M Vernet
Robert A Ballinger
Suresh G Shenoy
Ramesh Kekuda
Catherine E Burgess
Peter S Mezes
William M Grosse
John P Ii Alsobrook
Linda Gorman
William J Larochelle
Raymond J Taupier Jr
Steven D Colman
Edward S Szekeres Jr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curagen Corp, Kimberly A Spytek, Muralidhara Padigaru, Bryan D Zerhusen, Jason C Baumgartner, Li Li, Stacie J Casman, Corine A M Vernet, Robert A Ballinger, Suresh G Shenoy, Ramesh Kekuda, Catherine E Burgess, Peter S Mezes, William M Grosse, John P Ii Alsobrook, Linda Gorman, William J Larochelle, Raymond J Taupier Jr, Steven D Colman, Edward S Szekeres Jr filed Critical Curagen Corp
Priority to AU2001288237A priority Critical patent/AU2001288237A1/en
Publication of WO2002012343A2 publication Critical patent/WO2002012343A2/fr
Publication of WO2002012343A3 publication Critical patent/WO2002012343A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne des séquences d'acides nucléiques codant des polypeptides associés au récepteur couplé aux protéines G. L'invention concerne également des polypeptides codés par ces séquences d'acide nucléique, et des anticorps, se fixant de façon immunospécifique sur ce polypeptide, ainsi que des dérivés, des variants, des mutants, ou des fragments dudit polypeptide, polynucléotide, ou anticorps. L'invention concerne également des méthodes de thérapie, de diagnostic et de recherche destinées au diagnostic, au traitement et à la prévention de troubles associés à ces nouveaux acides nucléiques humains et à ces nouvelles protéines humaines.
PCT/US2001/024787 2000-08-07 2001-08-07 Nouvelles proteines et acides nucleiques les codant WO2002012343A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001288237A AU2001288237A1 (en) 2000-08-07 2001-08-07 Proteins and nucleic acids encoding g-protein coupled receptors

Applications Claiming Priority (32)

Application Number Priority Date Filing Date Title
US22347200P 2000-08-07 2000-08-07
US22313800P 2000-08-07 2000-08-07
US60/223,472 2000-08-07
US60/223,138 2000-08-07
US22481500P 2000-08-11 2000-08-11
US22461300P 2000-08-11 2000-08-11
US60/224,613 2000-08-11
US60/224,815 2000-08-11
US26000301P 2001-01-05 2001-01-05
US26007201P 2001-01-05 2001-01-05
US60/260,072 2001-01-05
US60/260,003 2001-01-05
US26028301P 2001-01-08 2001-01-08
US60/260,283 2001-01-08
US26045001P 2001-01-09 2001-01-09
US60/260,450 2001-01-09
US26115601P 2001-01-10 2001-01-10
US60/261,156 2001-01-10
US26333801P 2001-01-22 2001-01-22
US60/263,338 2001-01-22
US26343401P 2001-01-23 2001-01-23
US60/263,434 2001-01-23
US26570401P 2001-02-01 2001-02-01
US60/265,704 2001-02-01
US26996401P 2001-02-20 2001-02-20
US60/269,964 2001-02-20
US27487301P 2001-03-09 2001-03-09
US60/274,873 2001-03-09
US27640601P 2001-03-15 2001-03-15
US60/276,406 2001-03-15
US28791601P 2001-05-01 2001-05-01
US60/287,916 2001-05-01

Publications (2)

Publication Number Publication Date
WO2002012343A2 WO2002012343A2 (fr) 2002-02-14
WO2002012343A3 true WO2002012343A3 (fr) 2003-06-19

Family

ID=27585829

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/024787 WO2002012343A2 (fr) 2000-08-07 2001-08-07 Nouvelles proteines et acides nucleiques les codant

Country Status (2)

Country Link
AU (1) AU2001288237A1 (fr)
WO (1) WO2002012343A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001288237A1 (en) * 2000-08-07 2002-02-18 Curagen Corporation Proteins and nucleic acids encoding g-protein coupled receptors
WO2003000929A2 (fr) * 2001-06-26 2003-01-03 Sankyo Company, Limited Polynucleotides, polypeptides et cancer
DE10344799A1 (de) * 2003-09-26 2005-04-14 Ganymed Pharmaceuticals Ag Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie
AU2011213901B2 (en) * 2003-09-26 2012-07-05 BioNTech SE Identification of tumour-associated cell surface antigens for diagnosis and therapy
EP1698902A1 (fr) * 2005-03-01 2006-09-06 DKFZ Deutsches Krebsforschungszentrum Utilisation de XCR1 pour le diagnostic et surveillance de la tolérance immunitaire
DE102005013846A1 (de) * 2005-03-24 2006-10-05 Ganymed Pharmaceuticals Ag Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995018140A1 (fr) * 1993-12-28 1995-07-06 Yeda Research & Development Co., Ltd. Genes et recepteurs olfactifs
WO2002012343A2 (fr) * 2000-08-07 2002-02-14 Curagen Corporation Nouvelles proteines et acides nucleiques les codant

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995018140A1 (fr) * 1993-12-28 1995-07-06 Yeda Research & Development Co., Ltd. Genes et recepteurs olfactifs
WO2002012343A2 (fr) * 2000-08-07 2002-02-14 Curagen Corporation Nouvelles proteines et acides nucleiques les codant

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
GLUSMAN G ET AL: "SEQUENCE ANALYSIS IN THE OLFACTORY RECEPTOR GENE CLUSTER ON HUMAN CHROMOSOME 17: RECOMBINATORIAL EVENTS AFFECTING RECEPTOR DIVERSITY", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, vol. 37, no. 2, 1996, pages 147 - 160, XP000886076, ISSN: 0888-7543 *
KRAUTWURST D ET AL: "Identification of ligands for olfactory receptors by functional expression of a receptor library", CELL, CELL PRESS, CAMBRIDGE, NA, US, vol. 95, 25 June 1998 (1998-06-25), pages 917 - 926, XP002153217, ISSN: 0092-8674 *
MALNIC BETTINA ET AL: "Combinatorial receptor codes for odors", CELL, CELL PRESS, CAMBRIDGE, NA, US, vol. 96, no. 5, 5 March 1999 (1999-03-05), pages 713 - 723, XP002188611, ISSN: 0092-8674 *
THOMAS M B ET AL: "CHEMORECEPTORS EXPRESSED IN TASTE, OLFACTORY AND MALE PRODUCTIVE TISSUES", GENE, ELSEVIER BIOMEDICAL PRESS. AMSTERDAM, NL, vol. 178, no. 1/2, 1996, pages 1 - 5, XP002926154, ISSN: 0378-1119 *
TRASK B J ET AL: "Members of the olfactory receptor gene family are contained in large blocks of DNA duplicated polymorphically near the ends of human chromosomes", HUMAN MOLECULAR GENETICS, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 7, no. 1, January 1998 (1998-01-01), pages 13 - 26, XP002135641, ISSN: 0964-6906 *
WETZEL CHRISTIAN H ET AL: "Specificity and sensitivity of a human olfactory receptor functionally expressed in human embryonic kidney 293 cells and Xenopus laevis oocytes", JOURNAL OF NEUROSCIENCE, NEW YORK, NY, US, vol. 19, no. 17, 1 September 1999 (1999-09-01), pages 7426 - 7433, XP002178954, ISSN: 0270-6474 *

Also Published As

Publication number Publication date
AU2001288237A1 (en) 2002-02-18
WO2002012343A2 (fr) 2002-02-14

Similar Documents

Publication Publication Date Title
WO2002014368A8 (fr) Nouvelles proteines et acides nucleiques codant pour ces proteines
WO2002055705A3 (fr) Proteines et acides nucleiques codant ces proteines
WO2002064791A3 (fr) Proteines et acides nucleiques codant celles-ci
WO2002068649A3 (fr) Proteines et acides nucleiques les codant
WO2002057450A3 (fr) Proteines et acides nucleiques les codant
WO2004015060A3 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et methodes d'utilisation associees
WO2002016599A3 (fr) Nouvelles proteines et acides nucleiques les codant
WO2002068652A3 (fr) Proteines et acides nucleiques codant ces proteines
WO2001074904A3 (fr) Nouvelles proteines et acides nucleiques codant pour celles-ci
WO2002010216A3 (fr) Nouvelles proteines et acides nucleiques codant pour elles
WO2002079398A3 (fr) Polypeptides therapeutiques, les acides nucleiques les codant et leurs procedes d'utilisation
WO2001066747A8 (fr) Nouvelles proteines et acides nucleiques codant lesdites proteines
WO2002046229A3 (fr) Nouvelles proteines et acides nucleiques codant celles-ci
WO2002099116A8 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation
WO2001074851A3 (fr) Nouvelles proteines et acides nucleiques codant pour ces proteines
WO2002012343A3 (fr) Nouvelles proteines et acides nucleiques les codant
WO2002083841A3 (fr) Polypeptides therapeutiques, acides nucleiques les codant, et procedes d'utilisation
WO2001059113A3 (fr) Nouvelles proteines et acides nucleiques codant ces dernieres
WO2001090187A3 (fr) Nouvelles proteines et acides nucleiques codant celles-ci
WO2002026985A3 (fr) Nouvelles proteines et acides nucleiques codant ces proteines
WO2002008289A3 (fr) Nouvelles proteines et acides nucleiques codant ces proteines
WO2002059313A3 (fr) Nouvelles proteines, et acides nucleiques codant pour elles
WO2002002637A3 (fr) Nouvelles proteines et acides nucleiques les codant
WO2001094416A3 (fr) Nouvelles proteines et acides nucleiques qui les codent
WO2002030974A3 (fr) Nouvelles proteines et acides nucleiques codant pour celles-ci

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US US US US US US US US US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP